Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
6.17
-0.03 (-0.48%)
At close: Feb 13, 2026, 4:00 PM EST
6.19
+0.02 (0.32%)
After-hours: Feb 13, 2026, 4:00 PM EST
Inventiva Employees
Inventiva had 84 employees as of June 30, 2025. The number of employees decreased by 34 or -28.81% since the number was reported on December 31, 2024.
Employees
84
Change
-34
Growth
-28.81%
Revenue / Employee
$237,256
Profits / Employee
-$4,348,978
Market Cap
1.20B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 84 | -34 | -28.81% | 84 | 0 |
| Dec 31, 2024 | 118 | -5 | -4.07% | 114 | 4 |
| Dec 31, 2023 | 123 | 10 | 8.85% | 120 | 3 |
| Dec 31, 2022 | 113 | 8 | 7.62% | 109 | 4 |
| Dec 31, 2021 | 105 | 11 | 11.70% | 101 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 645 |
| Xeris Biopharma Holdings | 394 |
| Day One Biopharmaceuticals | 184 |
| Inhibrx Biosciences | 161 |
| Capricor Therapeutics | 160 |
| DBV Technologies | 117 |
| Nanobiotix | 103 |
| MoonLake Immunotherapeutics | 100 |
IVA News
- 9 days ago - Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 16 days ago - Biotech Inventiva's 50% surge shows investor optimism over liver disease drug - Reuters
- 4 weeks ago - Inventiva S.A. (IVA) Presents at 44th Annual J.P. - Seeking Alpha
- 3 months ago - Inventiva reports 2025 Third Quarter Financial Information¹ - GlobeNewsWire
- 3 months ago - Inventiva announces full exercise of Underwriters' Option, bringing proceeds of Offering to approximately $172.5M - GlobeNewsWire
- 3 months ago - Inventiva announces trading resumption of its ordinary shares on Euronext Paris - GlobeNewsWire
- 3 months ago - Inventiva announces pricing of upsized public offering of approximately $150M of American Depositary Shares - GlobeNewsWire
- 3 months ago - Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris - GlobeNewsWire